# Nuclear import of malaria RNA rewires splicing in host immune cells

**Authors:** Paula Abou Karam, Edo Kiper, Tamar Ziv, Shaked Yadid, Ewa Kozela, Nir Zharoni, Reinat Nevo, Daniel Alfandari, Helina Otesh, Abel Cruz Camacho, Yoav Lubelsky, Ron Rotkopf, Eviatar Weizman, Moshe Cossin, Irit Rosenhek-Goldian, Ekaterina Petrovich-Kopitman, Ziv Porat, Ofer Shoshani, Igor Ulitsky, Carmit Levy, Zeev Melamed, Neta Regev-Rudzki

PMC · DOI: 10.1016/j.celrep.2026.116953 · Cell Reports · 2026-02-13

## TL;DR

The malaria parasite uses its RNA to enter host immune cells' nuclei and disrupt RNA splicing, altering immune responses.

## Contribution

Discovery of an RNA-based mechanism by malaria parasites to interfere with host splicing machinery and immune signaling.

## Key findings

- Malaria mRNAs are imported into host nuclei and bind to splicing proteins ACIN1 and PNN.
- This binding disrupts host RNA splicing, leading to altered immune protein expression.
- The mechanism reveals a novel strategy for pathogen manipulation of host immunity.

## Abstract

Eukaryotic pathogens deploy diverse strategies to manipulate host immunity, yet RNA-based virulence mechanisms remain poorly understood. We describe a mechanism by which the malaria parasite Plasmodiumfalciparum governs host immune responses through direct interference with host nuclear RNA processing. Malaria-encoded mRNAs of the early transcribed membrane protein family, exported from infected red blood cells, evade cytoplasmic degradation within host immune cells and are imported into their highly secured nuclei. Inside the nucleus, parasite transcripts bind the host RNA-binding proteins ACIN1 and PNN, key components of the splicing machinery that associate with the exon junction complex. This interaction disrupts host splicing regulation, leading to widespread misprocessing of transcripts and altered expression of proteins involved in immune function. Our findings uncover an RNA-based strategy by which pathogen-derived transcripts exploit the host splicing machinery, reshaping transcript isoform landscapes and immune signaling.

•Plasmodium falciparum delivers three parasitic ETRAMP mRNAs into host monocytes via EVs•Delivered RNAs evade degradation, enter the protected host nucleus, and bind ACIN1/PNN•Host splicing dysregulation causes transcript misprocessing and altered immune response•An extracellular RNA-based mechanism shows how malaria reshapes host immune signaling

Plasmodium falciparum delivers three parasitic ETRAMP mRNAs into host monocytes via EVs

Delivered RNAs evade degradation, enter the protected host nucleus, and bind ACIN1/PNN

Host splicing dysregulation causes transcript misprocessing and altered immune response

An extracellular RNA-based mechanism shows how malaria reshapes host immune signaling

Abou Karam et al. identify a cell communication mechanism used by the malaria parasite Plasmodium falciparum. The parasite delivers its mRNAs into monocytes and imports them into their protected nuclei, where they perturb the splicing. This extracellular RNA-based strategy disrupts host transcript processing and immune signaling, revealing another layer of host interference.

## Linked entities

- **Genes:** ETRAMP (early transcribed membrane protein) [NCBI Gene 39728532]
- **Proteins:** ACIN1 (apoptotic chromatin condensation inducer 1), PNN (pinin, desmosome associated protein)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium falciparum (taxon 5833)

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7) [NCBI Gene 374291] {aka CI-20, CI-20KD, MC1DN3, MY017, PSST}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, MAP9 (microtubule associated protein 9) [NCBI Gene 79884] {aka ASAP}, RAB5A (RAB5A, member RAS oncogene family) [NCBI Gene 5868] {aka RAB5}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, ATAD2 (ATPase family AAA domain containing 2) [NCBI Gene 29028] {aka ANCCA, CT137, PRO2000}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, RHOT2 (ras homolog family member T2) [NCBI Gene 89941] {aka ARHT2, C16orf39, MIRO-2, MIRO2, RASL}, SCLY (selenocysteine lyase) [NCBI Gene 51540] {aka SCL, hSCL}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IFIT3 (interferon induced protein with tetratricopeptide repeats 3) [NCBI Gene 3437] {aka CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60}, NHLRC2 (NHL repeat containing 2) [NCBI Gene 374354] {aka FINCA}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, GFI1 (growth factor independent 1 transcriptional repressor) [NCBI Gene 2672] {aka GFI-1, GFI1A, SCN2, ZNF163}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, FN3KRP (fructosamine 3 kinase related protein) [NCBI Gene 79672] {aka FN3KL}, CNOT3 (CCR4-NOT transcription complex subunit 3) [NCBI Gene 4849] {aka IDDSADF, LENG2, NOT3, NOT3H}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, PSAP (prosaposin) [NCBI Gene 5660] {aka GLBA, PARK24, PSAPD, SAP1, SAP2}, TEX264 (testis expressed 264, ER-phagy receptor) [NCBI Gene 51368] {aka ZSIG11}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, LMNB2 (lamin B2) [NCBI Gene 84823] {aka EPM9, LAMB2, LMN2, MCPH27}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ENOPH1 (enolase-phosphatase 1) [NCBI Gene 58478] {aka E1, MASA, MST145, mtnC}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, CANX (calnexin) [NCBI Gene 821] {aka CNX, IP90, P90}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, TPX2 (TPX2 microtubule nucleation factor) [NCBI Gene 22974] {aka C20orf1, C20orf2, DIL-2, DIL2, FLS353, GD:C20orf1}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, ACIN1 (apoptotic chromatin condensation inducer 1) [NCBI Gene 22985] {aka ACINUS, ACN, fSAP152}, RAB7B (RAB7B, member RAS oncogene family) [NCBI Gene 338382] {aka RAB7}, RPS11 (ribosomal protein S11) [NCBI Gene 6205] {aka S11, uS17}, ZWINT (ZW10 interacting kinetochore protein) [NCBI Gene 11130] {aka HZwint-1, KNTC2AP, SIP30, ZWINT1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, MX2 (MX dynamin like GTPase 2) [NCBI Gene 4600] {aka MXB}, PCYT2 (phosphate cytidylyltransferase 2, ethanolamine) [NCBI Gene 5833] {aka ET, SPG82}, OAS2 (2'-5'-oligoadenylate synthetase 2) [NCBI Gene 4939] {aka AIAISD2}, PNN (pinin, desmosome associated protein) [NCBI Gene 5411] {aka DRS, DRSP, SDK3, memA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}
- **Diseases:** fungal infection (MESH:D009181), Plasmodium infection (MESH:D008288), mosquito-borne parasitic disease (MESH:D000079426), infectious diseases (MESH:D003141), tuberculosis infection (MESH:D014376), infection (MESH:D007239), immune dysfunction (MESH:D007154), parasitemia (MESH:D018512), cerebral and placental malaria (MESH:D016779), Plasmodium vivax infections (MESH:D016780), cancer (MESH:D009369), inflammatory (MESH:D007249), monocytic leukemia (MESH:D007951), AS (MESH:C536589)
- **Chemicals:** PBS (MESH:D007854), Tween 20 (MESH:D011136), KCl (MESH:D011189), L-lysine (MESH:D008239), LiCl (MESH:D018021), cycloheximide (MESH:D003513), DMSO (MESH:D004121), Ca+ (MESH:D002118), Reprosil (MESH:C034183), EGTA (MESH:D004533), CO2 (MESH:D002245), cysteine (MESH:D003545), sucrose (MESH:D013395), LPS (MESH:D008070), nitrogen compound (MESH:D017672), amino acids (MESH:D000596), urea (MESH:D014508), Hoechst 33342 (MESH:C017807), ammonium bicarbonate (MESH:C027043), L-arginine (MESH:D001120), Albumax II (-), sodium bicarbonate (MESH:D017693), silica (MESH:D012822), HEPES (MESH:D006531), penicillin (MESH:D010406), essential amino acids (MESH:D000601), DTT (MESH:D004229), oligonucleotides (MESH:D009841), Biotin (MESH:D001710), gentamycin (MESH:D005839), SDS (MESH:D012967), acetic acid (MESH:D019342), ethanol (MESH:D000431), 13C (MESH:C000615229), NaOH (MESH:D012972), water (MESH:D014867), Sorbitol (MESH:D013012), peptides (MESH:D010455), Trizol (MESH:C411644), iodoacetamide (MESH:D007460), DPBS (MESH:C012939), N2 (MESH:D009584), EDTA (MESH:D004492), Thiazole orange (MESH:C051000), mica (MESH:C011934), acetonitrile (MESH:C032159), DDM (MESH:C117975), streptomycin (MESH:D013307), MgCl2 (MESH:D015636), methionine (MESH:D008715), NaCl (MESH:D012965), sodium deoxycholate (MESH:D003840), methanol (MESH:D000432), formic acid (MESH:C030544), TCEP (MESH:C080938), acids (MESH:D000143), hypoxanthine (MESH:D019271)
- **Species:** Influenza A virus (no rank) [taxon 11320], West Nile virus (no rank) [taxon 11082], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Homo sapiens (human, species) [taxon 9606], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702], Pf [taxon 1985359], Human immunodeficiency virus 1 (no rank) [taxon 11676], Mycoplasma (genus) [taxon 2093], Hepatitis delta virus (no rank) [taxon 12475], Mus musculus (house mouse, species) [taxon 10090], Plasmodium falciparum NF54 (isolate) [taxon 5843]
- **Mutations:** S1420S, E2040S
- **Cell lines:** EJC — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B2IL), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932926/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932926/full.md

## References

112 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932926/full.md

---
Source: https://tomesphere.com/paper/PMC12932926